Core Insights - Neogen (NEOG) reported a revenue of $224.69 million for the quarter ended November 2025, reflecting a year-over-year decline of 2.8% and an EPS of $0.10, down from $0.11 in the same quarter last year. However, the revenue exceeded the Zacks Consensus Estimate of $209.74 million by 7.13% [1] Revenue Performance - Animal Safety revenues were $59.14 million, surpassing the average estimate of $56.56 million, but showing a year-over-year decline of 11.8% [4] - Food Safety revenues reached $165.55 million, exceeding the average estimate of $153.19 million, with a slight year-over-year increase of 0.8% [4] - Specific revenue breakdowns include: - Indicator Testing, Culture Media & Other: $86.11 million, exceeding estimates of $76.36 million, with a year-over-year increase of 3.4% [4] - Life Sciences under Animal Safety: $1.45 million, below the estimate of $1.6 million, reflecting an 11% decline year-over-year [4] - Veterinary Instruments & Disposables: $13.68 million, below the estimate of $15.68 million, showing a year-over-year decline of 20.8% [4] - Animal Care & Other: $8.89 million, below the estimate of $10.41 million, with a year-over-year decline of 9% [4] - Natural Toxins & Allergens: $20.44 million, slightly above the estimate of $19.1 million, with a year-over-year change of -0.3% [4] - Genomics Services under Animal Safety: $17.18 million, significantly above the estimate of $4.83 million [4] - Genomics Services under Food Safety: $6.26 million, below the estimate of $13.93 million [4] - Biosecurity Products under Food Safety: $4.57 million, below the estimate of $8.74 million [4] - Bacterial & General Sanitation: $44.92 million, exceeding the estimate of $39.28 million, with a year-over-year increase of 5.6% [4] - Biosecurity Products under Animal Safety: $17.93 million, slightly below the estimate of $18.7 million [4] Stock Performance - Neogen's shares have returned +5.7% over the past month, outperforming the Zacks S&P 500 composite, which saw a +0.9% change [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]

The market expects JB Hunt (JBHT) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on ...

WaFd (WAFD) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The stock might move higher if these key numbers top expectations in the upcoming earnings report. On the other hand, if they miss, the stock may move ...

Shares of O-I Glass (OI) have been strong performers lately, with the stock up 2.6% over the past month. The stock hit a new 52-week high of $16.04 in the previous session. O-I Glass has gained 2.8% since the start of the year compared to the 8.2% move for the Zacks Industrial Products sector and the -6.1% return for the Zacks Glass Products industry.What's Driving the Outperformance?The stock has an impressive record of positive earnings surprises, as it hasn't missed our earnings consensus estimate in an ...

Wall Street expects a year-over-year increase in earnings on higher revenues when United Community Banks (UCB) reports results for the quarter ended December 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on January 14, might help the stock move higher if these key numbers are better t ...

Illinois-based Mondelez International, Inc. (MDLZ) is a leading global snack food company focused on biscuits, chocolate, confectionery and gum, with operations spanning more than 150 countries. Formed in 2012, the company owns a portfolio of iconic, billion-dollar brands such as Oreo, Cadbury, Milka, Ritz, Toblerone and Sour Patch Kids. It is currently valued at a market cap of $69.2 billion. The company is set to announce its fourth-quarter results soon. Ahead of the event, analysts expect Mondelez to ...

Tyson Foods, Inc. (TSN), headquartered in Springdale, Arkansas, stands as a global leader in protein production. The company produces raw meat products, including fresh beef, pork, and chicken, as well as prepared foods such as nuggets, wings, sausages, and ready-to-eat meals, for consumers worldwide. Through vertical integration, it manages the entire supply chain, from farming and livestock raising to processing and distribution, ensuring efficiency, quality control, and reliable delivery to global mar ...

Core Viewpoint - Wall Street anticipates a year-over-year decline in earnings for Franklin Covey, with a consensus outlook indicating a significant drop in revenues and earnings per share (EPS) for the quarter ending November 2025 [1][3]. Earnings Expectations - Franklin Covey is expected to report quarterly earnings of $0.03 per share, reflecting a year-over-year decrease of 66.7% [3]. - Revenues are projected to be $64.66 million, down 6.4% from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised 8% higher in the last 30 days, indicating a reassessment by analysts [4]. - A positive Earnings ESP of +50.00% suggests that analysts have recently become more optimistic about the company's earnings prospects [12]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive reading is a strong predictor of an earnings beat, especially when combined with a Zacks Rank of 1, 2, or 3 [10]. - Franklin Covey currently holds a Zacks Rank of 3, which, along with the positive Earnings ESP, suggests a likelihood of beating the consensus EPS estimate [12]. Historical Performance - In the last reported quarter, Franklin Covey was expected to post earnings of $0.43 per share but delivered only $0.34, resulting in a surprise of -20.93% [13]. - Over the past four quarters, the company has beaten consensus EPS estimates two times [14]. Conclusion - While Franklin Covey is positioned as a potential earnings-beat candidate, investors should consider other factors that may influence stock performance beyond just earnings results [15][17].

The market expects Constellation Brands (STZ) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended November 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on January 7, might help the stock move higher if these key numbers a ...

The market expects Kura Sushi (KRUS) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended November 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released ...